| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361783376P | 2013-03-14 | 2013-03-14 | |
| EP14719977.2AEP2968301B1 (en) | 2013-03-14 | 2014-03-14 | Combination of two antivirals for treating hepatitis c |
| Publication Number | Publication Date |
|---|---|
| DK3213750T3true DK3213750T3 (da) | 2020-10-19 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK14719977.2TDK2968301T3 (da) | 2013-03-14 | 2014-03-14 | Kombination af to antiviraler til behandling af hepatitis c |
| DK17165207.6TDK3213750T3 (da) | 2013-03-14 | 2014-03-14 | Kombination af to antivirale midler til behandling af hepatitis c |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK14719977.2TDK2968301T3 (da) | 2013-03-14 | 2014-03-14 | Kombination af to antiviraler til behandling af hepatitis c |
| Country | Link |
|---|---|
| US (1) | US20140275099A1 (da) |
| EP (3) | EP2968301B1 (da) |
| JP (4) | JP6441303B2 (da) |
| KR (2) | KR102210935B1 (da) |
| CN (2) | CN105073113B (da) |
| AU (2) | AU2014239563B2 (da) |
| BR (1) | BR112015023017B1 (da) |
| CA (1) | CA2901810C (da) |
| CY (2) | CY1119025T1 (da) |
| DK (2) | DK2968301T3 (da) |
| EA (2) | EA201991174A1 (da) |
| ES (2) | ES2824473T3 (da) |
| HR (2) | HRP20171036T1 (da) |
| HU (2) | HUE052113T2 (da) |
| IL (1) | IL240419B (da) |
| LT (2) | LT3213750T (da) |
| MX (3) | MX362616B (da) |
| NZ (2) | NZ631155A (da) |
| PL (2) | PL3213750T3 (da) |
| PT (2) | PT2968301T (da) |
| RS (2) | RS56202B1 (da) |
| SG (2) | SG10201708306WA (da) |
| SI (2) | SI2968301T1 (da) |
| TW (2) | TWI642436B (da) |
| WO (1) | WO2014152514A1 (da) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11484534B2 (en) | 2013-03-14 | 2022-11-01 | Abbvie Inc. | Methods for treating HCV |
| HRP20171036T1 (hr) | 2013-03-14 | 2017-10-06 | Abbvie Inc. | Kombinacija dvaju antiviralnih sredstava za liječenje hepatitisa c |
| EP3016651A1 (en)* | 2013-07-02 | 2016-05-11 | AbbVie Inc. | Methods for treating hcv |
| CA2925328A1 (en)* | 2013-10-25 | 2015-04-30 | Abbvie, Inc. | Methods for treating hcv |
| WO2015095572A1 (en)* | 2013-12-19 | 2015-06-25 | Abbvie Inc. | Methods for treating liver transplant recipients |
| AU2015240754B2 (en)* | 2014-04-02 | 2020-06-25 | Abbvie Inc. | Methods for treating HCV |
| AU2015240753B2 (en)* | 2014-04-02 | 2020-01-16 | Abbvie Inc. | Methods for treating HCV |
| US20160375017A1 (en) | 2015-06-26 | 2016-12-29 | Abbvie Inc. | Solid Pharmaceutical Compositions for Treating HCV |
| EP3313378A1 (en)* | 2015-06-26 | 2018-05-02 | AbbVie Inc. | Solid pharmaceutical compositions for treating hcv |
| US20230385268A1 (en)* | 2022-05-17 | 2023-11-30 | Abbvie Inc. | Methods for Treating HCV |
| JP6808660B2 (ja)* | 2015-07-08 | 2021-01-06 | アッヴィ・インコーポレイテッド | Ｈｃｖを処置するための方法 |
| IL256945B2 (en)* | 2015-07-17 | 2023-10-01 | Abbvie Inc | Solid pharmaceutical compositions comprising a combination of two compounds for treating hepatitis c virus infection |
| JP7129703B2 (ja) | 2016-04-28 | 2022-09-02 | エモリー ユニバーシティー | アルキン含有ヌクレオチド及びヌクレオシド治療組成物並びにそれらに関連した使用 |
| US20180085330A1 (en)* | 2016-09-23 | 2018-03-29 | Abbvie Inc. | Dose Adjustment |
| JP2018131439A (ja)* | 2017-02-14 | 2018-08-23 | アッヴィ・インコーポレイテッド | Ｈｃｖを処置する方法 |
| CA2981993A1 (en)* | 2017-08-02 | 2019-02-02 | Abbvie Inc. | Methods for treating hcv |
| TW202012001A (zh)* | 2018-04-10 | 2020-04-01 | 美商亞堤製藥公司 | C型肝炎病毒(hcv)感染硬化之患者的治療 |
| EP3883569A1 (en) | 2018-11-20 | 2021-09-29 | Abbvie Inc. | Methods for treating acute hcv |
| KR102077833B1 (ko) | 2018-12-10 | 2020-02-14 | 류형준 | 기능성 식품조성물 |
| CN111688355B (zh) | 2019-03-15 | 2022-04-12 | 精工爱普生株式会社 | 液体吸收体、液体吸收器以及液体喷出装置 |
| CN113645958A (zh)* | 2019-04-08 | 2021-11-12 | 艾伯维公司 | 用于治疗hcv的固体药物组合物 |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8937150B2 (en)* | 2009-06-11 | 2015-01-20 | Abbvie Inc. | Anti-viral compounds |
| US9394279B2 (en)* | 2009-06-11 | 2016-07-19 | Abbvie Inc. | Anti-viral compounds |
| AR083052A1 (es)* | 2010-09-21 | 2013-01-30 | Enanta Pharm Inc | Inhibidores de las proteasas de serina del vhc derivados de prolinas macrociclicas |
| US8330139B2 (en) | 2011-03-25 | 2012-12-11 | Micron Technology, Inc. | Multi-level memory cell |
| DK2583677T1 (da) | 2011-10-21 | 2015-01-19 | Abbvie Inc | Fremgangsmåder til behandling af HCV omfattende mindst to direktevirkende antivirale midler, ribavirin, men ikke inteferon |
| PT107925A (pt) | 2011-10-21 | 2014-12-03 | Abbvie Inc | Tratamento de combinação de daa (eg. com abt-072 ou abt-333) para utilização no tratamento de hcv |
| JP6297044B2 (ja)* | 2012-09-18 | 2018-03-20 | アッヴィ・インコーポレイテッド | Ｃ型肝炎を治療するための方法 |
| HRP20171036T1 (hr) | 2013-03-14 | 2017-10-06 | Abbvie Inc. | Kombinacija dvaju antiviralnih sredstava za liječenje hepatitisa c |
| Publication | Publication Date | Title |
|---|---|---|
| DK3213750T3 (da) | Kombination af to antivirale midler til behandling af hepatitis c | |
| DK3121164T3 (da) | Sulfamoylpyrrolamidderivater og anvendelse deraf som medikamenter til behandling af hepatitis b | |
| DK2950786T3 (da) | Kombinationsformulering af to antivirale forbindelser | |
| DK2981255T3 (da) | Terapeutiske anvendelser af empagliflozin | |
| HRP20181679T1 (hr) | Amidni spojevi za liječenje hiv | |
| DK2961388T3 (da) | Kombinationer af lægemidler | |
| DK2968208T3 (da) | Behandling af kataplexi | |
| DK2958900T3 (da) | 2-aminopyrimidinderivater til behandling af virusinfektioner | |
| HRP20180684T1 (hr) | Kombinacija lijekova | |
| PL2970412T3 (pl) | Aktywacja bioluminescencji przez dopełnienie strukturalne | |
| HRP20190101T1 (hr) | Terapeutske uporabe empagliflozina | |
| BR302013004506S1 (pt) | Configuração aplicada em jóias | |
| BR302013004540S1 (pt) | Configuração aplicada em jóias | |
| BR302013004355S1 (pt) | Configuração aplicada em jóias | |
| EP2973379A4 (en) | PERSONALIZED ABSTRACT FOR CONTENT | |
| EP3016703C0 (en) | Safety syringe | |
| DK3626270T3 (da) | Behandling af kardiovaskulære sygdomme | |
| BR302013005134S1 (pt) | Configuração aplicada em alça de cateter | |
| EP4005604C0 (en) | ADMINISTRATION OF MEDICINES | |
| DK3010895T3 (da) | Fremgangsmåde til fremstilling af 4-propargyleret aminobenzoxazinoner | |
| DK3062811T3 (da) | Angiopoietin-baserede interventioner til behandling af cerebral malaria | |
| DK3003366T3 (da) | På hinanden følgende overlappende peptider til behandling af allergi overfor husstøvmider | |
| DK3360869T3 (da) | Halogen-substitueret heterocyklisk forbindelse anvendelig til behandlingen af sygdomme forårsaget af lpa. | |
| DK3511004T3 (da) | Kombineret præparat til behandling af cancer | |
| DK3024519T3 (da) | Destruktion af hypodermiske kanyler |